Extended Treatment with Micron-Size Oral Palmitoylethanolamide (PEA) in Chronic Pain: A Systematic Review and Meta-Analysis
Nutrients · 28.05.2024 · 16 (11) · 1653
DOI: 10.3390/nu16111653 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Nutrients, online erschienen am 28.05.2024. Verfasst von Vittorio Schweiger und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesia, Intensive Care and Pain Therapy, Verona University Hospital, 37134 Verona, Italy. Hauptthemen laut MEDLINE: Palmitic Acids, Amides, Ethanolamines, Chronic Pain. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Schmerzmanagement
Abstract (Originalsprache)
Palmitoylethanolamide (PEA) emerged over the years as a promising approach in the management of chronic pain. Despite the fact that the efficacy of micron-size PEA formulations appears to be time-dependent, the optimal timing has not yet been elucidated. This systematic review and meta-analysis aim to estimate the possible advantage of an extended treatment in the relief of chronic pain. The literature search was conducted consulting scientific databases, to identify clinical trials in which micron-size PEA was administered for at least 60 days, and pain assessed by the Visual Analogue Scale (VAS) or Numeric Rating Scale (NRS). Nine studies matched the required criteria, for a total of 742 patients involved. The meta-analysis showed a statistically and clinically significant pain intensity reduction after 60 days of micron-size PEA supplementation, compared to 30 days (1.36 points, p < 0.01). The secondary analysis revealed a weighted NRS/VAS score decrease of 2.08 points within the first month of treatment. These two obtained scores corresponded to a 35.1% pain intensity reduction within the first month, followed by a further 35.4% during the second month. Overall, these results confirm the clinically relevant and time-depended pain-relieving effect of micron-size PEA and therefore the advantage of an extended treatment, especially in patient with incomplete pain management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Anesthesia, Intensive Care and Pain Therapy, Verona University Hospital, 37134 Verona, Italy.
- Innovative Statistical Research, 35100 Padua, Italy.
- Department of Medicine and Public Health, Section of Forensic Medicine, University of Verona, 37134 Verona, Italy.
- Department of Medical Sciences and Public Health, University of Cagliari, 09042 Cagliari, Italy.
- Paolo Procacci Foundation, 00193 Rome, Italy.
ORCID-Profile: Carlo Schievano, Gabriele Finco, Giustino Varrassi
Zitieren
APA
Schweiger, V., Schievano, C., Martini, A., Polati, L., Del Balzo, G., Simari, S., Milan, B., Finco, G., Varrassi, G., & Polati, E. (2024). Extended Treatment with Micron-Size Oral Palmitoylethanolamide (PEA) in Chronic Pain: A Systematic Review and Meta-Analysis. Nutrients, 16(11), 1653. https://doi.org/10.3390/nu16111653
Vancouver
Schweiger V, Schievano C, Martini A, Polati L, Del Balzo G, Simari S, et al. Extended Treatment with Micron-Size Oral Palmitoylethanolamide (PEA) in Chronic Pain: A Systematic Review and Meta-Analysis. Nutrients. 2024;16(11):1653. doi:10.3390/nu16111653
BibTeX
@article{Schweiger2024,
author = {Schweiger, Vittorio and Schievano, Carlo and Martini, Alvise and Polati, Luca and Del Balzo, Giovanna and Simari, Salvatore and Milan, Beatrice and Finco, Gabriele and Varrassi, Giustino and Polati, Enrico},
title = {Extended Treatment with Micron-Size Oral Palmitoylethanolamide (PEA) in Chronic Pain: A Systematic Review and Meta-Analysis},
journal = {Nutrients},
year = {2024},
volume = {16},
number = {11},
pages = {1653},
doi = {10.3390/nu16111653}
}
EUVIMED